Log in
Enquire now
Catamaran Bio

Catamaran Bio

Catamaran uses NK cells, synthetic biology, and non-viral cell engineering to create novel CAR-NK cell therapies.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
CEO
Alvin Shih
Alvin Shih
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...aran-bio
Email Address
opportunities@catamaranbio.com
Founded Date
2020
Founder
‌
Kevin Pojasek
Branden S. Moriarity
Branden S. Moriarity
Full Address
451 D Street Boston, MA 02210
Industry
Oncology
Oncology
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Synthetic biology
Synthetic biology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Cell therapy
Cell therapy
Stem cell
Stem cell
•••
Invested in
Innoviti Payment Solutions Pvt Ltd
Innoviti Payment Solutions Pvt Ltd
Investors
Astellas Venture Management
Astellas Venture Management
SV Health Investors
SV Health Investors
Lightstone Ventures
Lightstone Ventures
Takeda Ventures
Takeda Ventures
Sofinnova Partners
Sofinnova Partners
Latest Funding Round Date
November 2020
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/catamaran-bio
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Boston
Boston
Total Funding Amount (USD)
42,000,000
Official Website
catamaranbio.com

Find more companies like Catamaran Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.